Wakabayashi Kuninobu

Researcher

基本情報

Profile and Settings

• 氏名

  Wakabayashi Kuninobu

Affiliation

• Rheumatology, Associate Professor

Location

• East Hospital

Degree

• Doctor of Medical Science, Showa University, Jan. 2012

Achievements

Published Papers

• Predictors of cytomegalovirus infection in patients with connective tissue disease treated by pulsed methylprednisolone therapy: a multicenter retrospective cohort study., Ito Haruka;Yoshimoto Takahiko;Kokaze Akatsuki;Wakabayashi Kuninobu;Noguchi Kazuteru;Matsui Kiyoshi;Natsumoto Bunki;Fujio Keishi;Hayashi Yutaro;Kaneko Yuko;Gono Takahisa;Okamoto Koh;Okugawa Shu;Moriya Kyoji;Sueki Hirohiko, BMC infectious diseases, 25(1):137 - 137, Jan. 2025, Peer-reviewed
• 筋炎関連抗体と間質性肺疾患, 西見　慎一郎;若林　邦伸, 昭和学士会雑誌, 83(3):190 - 197, Jun. 2023, Peer-reviewed, DOI:https://doi.org/10.14930/jshowaunivsoc.83.190
• Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis., Kuninobu Wakabayashi; Takeo Isozaki; Yumi Tsubokura; Sayaka Fukuse; Tsuyoshi Kasama, Scientific reports, 11(1):7937 - 7937, Apr. 2021
• Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis., Kuninobu Wakabayashi; Takeo Isozaki; Yumi Tsubokura; Sayaka Fukuse; Tsuyoshi Kasama, Scientific reports, 11(1):7937 - 7937, Apr. 2021
• Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis., Kuninobu Wakabayashi; Takeo Isozaki; Yumi Tsubokura; Sayaka Fukuse; Tsuyoshi Kasama, Scientific reports, 11(1):7937 - 7937, Apr. 2021
• RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain, Yutao Wen; Shen Yang; Kuninobu Wakabayashi; Mattias N. D. Svensson; Stephanie M. Stanford; Eugenio Santelli; Nunzio Bottini, Journal of Biological Chemistry, 295(15):4923 - 4936, Apr. 2020
• RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain, Yutao Wen; Shen Yang; Kuninobu Wakabayashi; Mattias N. D. Svensson; Stephanie M. Stanford; Eugenio Santelli; Nunzio Bottini, Journal of Biological Chemistry, 295(15):4923 - 4936, Apr. 2020
• RPTPα phosphatase activity is allosterically regulated by the membrane-distal catalytic domain, Yutao Wen; Shen Yang; Kuninobu Wakabayashi; Mattias N. D. Svensson; Stephanie M. Stanford; Eugenio Santelli; Nunzio Bottini, Journal of Biological Chemistry, 295(15):4923 - 4936, Apr. 2020
• A Disintegrin and Metalloprotease 15 is Expressed on Rheumatoid Arthritis Synovial Tissue Endothelial Cells and may Mediate Angiogenesis., Nishimi Shinichiro;Isozaki Takeo;Wakabayashi Kuninobu;Takeuchi Hiroko;Kasama Tsuyoshi, Cells, 8(1):e32, Jan. 2019, Peer-reviewed, DOI:10.3390/cells8010032
• Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease (Clinical Rheumatology, (2018), 37, 4, (1017-1024), 10.1007/s10067-018-4014-5), Airi Nishimi; Takeo Isozaki; Shinichiro Nishimi; Sho Ishii; Takahiro Tokunaga; Hidekazu Furuya; Kuninobu Wakabayashi; Tsuyoshi Kasama, Clinical Rheumatology, 37(4):1017 - 1024, Apr. 2018
• Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease (Clinical Rheumatology, (2018), 37, 4, (1017-1024), 10.1007/s10067-018-4014-5), Airi Nishimi; Takeo Isozaki; Shinichiro Nishimi; Sho Ishii; Takahiro Tokunaga; Hidekazu Furuya; Kuninobu Wakabayashi; Tsuyoshi Kasama, Clinical Rheumatology, 37(4):1017 - 1024, Apr. 2018
• Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease (Clinical Rheumatology, (2018), 37, 4, (1017-1024), 10.1007/s10067-018-4014-5), Airi Nishimi; Takeo Isozaki; Shinichiro Nishimi; Sho Ishii; Takahiro Tokunaga; Hidekazu Furuya; Kuninobu Wakabayashi; Tsuyoshi Kasama, Clinical Rheumatology, 37(4):1017 - 1024, Apr. 2018
• Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease., Nishimi A; Isozaki T; Nishimi S; Ishii S; Tokunaga T; Furuya H; Wakabayashi K; Kasama T, Clinical rheumatology, 37(4):1025 - 1026, Apr. 2018
• Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease., Nishimi A; Isozaki T; Nishimi S; Ishii S; Tokunaga T; Furuya H; Wakabayashi K; Kasama T, Clinical rheumatology, 37(4):1025 - 1026, Apr. 2018
• Correction to: ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease., Nishimi A; Isozaki T; Nishimi S; Ishii S; Tokunaga T; Furuya H; Wakabayashi K; Kasama T, Clinical rheumatology, 37(4):1025 - 1026, Apr. 2018
• ADAM-17 is expressed in the inflammatory myopathy and is involved with interstitial lung disease., Nishimi Airi;Isozaki Takeo;Nishimi Shinichiro;Ishii Sho;Tokunaga Takahiro;Furuya Hidekazu;Wakabayashi Kuninobu;Kasama Tsuyoshi, Clinical rheumatology, 37(4):1017 - 1024, Feb. 2018, Peer-reviewed
• Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone, MIWA Yusuke;NISHIMI Airi;NISHIMI Shinichiro;SAITO Mayu;TOKUNAGA Takahiro;YANAI Ryo;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;KASAMA Tsuyoshi;HOSAKA Michio, Eur J Rheumatol, 1(4):147 - 149, Dec. 2014, Peer-reviewed
• Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone., Miwa Y; Nishimi A; Nishimi S; Saito M; Tokunaga T; Yanai R; Takahashi R; Wakabayashi K; Kasama T; Hosaka M, European journal of rheumatology, 1(4):147 - 149, Dec. 2014
• Combined infliximab and methotrexate treatment improves the depressive state in rheumatoid arthritis patients more effectively than methotrexate alone., Miwa Y; Nishimi A; Nishimi S; Saito M; Tokunaga T; Yanai R; Takahashi R; Wakabayashi K; Kasama T; Hosaka M, European journal of rheumatology, 1(4):147 - 149, Dec. 2014
• 関節リウマチ患者に対する生物学的製剤の有効性の度合いとQOL、抑うつ状態の改善度合いの関係について, 三輪　裕介;穂坂　路男;松島　大輔;梅村　方裕;磯島　咲子;徳永　剛広;塚本　裕之;古屋　秀和;柳井　亮;大塚　久美子;髙橋　良;若林　邦伸;矢嶋　宣幸;笠間　毅;真田　建史, 心身医学, 54(1):59 - 66, Jan. 2014, Peer-reviewed
• Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents, Yusuke Miwa; Michio Hosaka; Kumiko Ohtsuka; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Tsuyoshi Odai; Nobuyuki Yajima; Tsuyoshi Kasama, MODERN RHEUMATOLOGY, 23(5):920 - 924, Sep. 2013, Peer-reviewed
• Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease., WAKABAYASHI Kuninobu;INOKUMA Shigeko;MATSUBARA Erika;ONISHI Kae;ASASHIMA Hiromitsu;NAKACHI Shinichiro;HAGIWARA Kiyofumi, Clin Rheumatol, 32(7):999 - 1005, Jul. 2013, Peer-reviewed
• Serum beta(2)-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease, Kuninobu Wakabayashi; Shigeko Inokuma; Erika Matsubara; Kae Onishi; Hiromitsu Asashima; Shinichiro Nakachi; Kiyofumi Hagiwara, CLINICAL RHEUMATOLOGY, 32(7):999 - 1005, Jul. 2013
• Serum beta(2)-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease, Kuninobu Wakabayashi; Shigeko Inokuma; Erika Matsubara; Kae Onishi; Hiromitsu Asashima; Shinichiro Nakachi; Kiyofumi Hagiwara, CLINICAL RHEUMATOLOGY, 32(7):999 - 1005, Jul. 2013
• 血管炎 ANCA関連血管炎における血漿FDP値の検討(第2報), 若林 邦伸; 梅村 方裕; 徳永 剛広; 塚本 裕之; 磯島 咲子; 古屋 秀和; 柳井 亮; 大塚 久美子; 高橋 良; 矢嶋 宣幸; 三輪 裕介; 笠間 毅, 日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集, 57回・22回:431 - 431, Mar. 2013
• 血管炎 ANCA関連血管炎における血漿FDP値の検討(第2報), 若林 邦伸; 梅村 方裕; 徳永 剛広; 塚本 裕之; 磯島 咲子; 古屋 秀和; 柳井 亮; 大塚 久美子; 高橋 良; 矢嶋 宣幸; 三輪 裕介; 笠間 毅, 日本リウマチ学会総会・学術集会・国際リウマチシンポジウムプログラム・抄録集, 57回・22回:431 - 431, Mar. 2013
• 関節リウマチ患者に対する生物学的製剤の有効性はQOL、抑うつ状態に影響を及ぼすか, 三輪　裕介;穂坂　路男;松島　大輔;古屋　秀和;大塚　久美子;佐藤　理仁;髙橋　良;若林　邦伸;小田井　剛;矢嶋　宣幸;笠間　毅;真田　建史, 心身医学, 52(4):309 - 314, Apr. 2012
• Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity, Kuninobu Wakabayashi; Kumiko Otsuka; Michihito Sato; Ryo Takahashi; Tsuyoshi Odai; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama, MODERN RHEUMATOLOGY, 22(1):59 - 65, Feb. 2012
• Eosinophilic Gastroenteritis due to Cow's Milk Allergy Presenting with Acute Pancreatitis, Shintaro Suzuki; Tetsuya Homma; Masatsugu Kurokawa; Satoshi Matsukura; Mitsuru Adachi; Kuninobu Wakabayashi; Fumihiko Nozu; Toshiyuki Tazaki; Teruaki Kimura; Takayuki Matsuura; Mitsuru Fukuda; Eisuke Shiozawa; Masafumi Takimoto, INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 158:75 - 82, 2012
• Eosinophilic Gastroenteritis due to Cow's Milk Allergy Presenting with Acute Pancreatitis, Shintaro Suzuki; Tetsuya Homma; Masatsugu Kurokawa; Satoshi Matsukura; Mitsuru Adachi; Kuninobu Wakabayashi; Fumihiko Nozu; Toshiyuki Tazaki; Teruaki Kimura; Takayuki Matsuura; Mitsuru Fukuda; Eisuke Shiozawa; Masafumi Takimoto, INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 158:75 - 82, 2012
• P137 Clinically amyopathic dermatomyositis (CADM)の活動性の評価に血清β_2-microglobulin値が有用であった1例(自己免疫疾患,ポスターセッション,第24回日本アレルギー学会春季臨床大会), 若林 邦伸; 猪熊 茂子; 松原 絵里佳; 大西 香絵; 浅島 弘充; 仲地 真一郎; 萩原 清文; 小林 祥子, アレルギー, 61(3):540 - 540, 2012
• P137 Clinically amyopathic dermatomyositis (CADM)の活動性の評価に血清β_2-microglobulin値が有用であった1例(自己免疫疾患,ポスターセッション,第24回日本アレルギー学会春季臨床大会), 若林 邦伸; 猪熊 茂子; 松原 絵里佳; 大西 香絵; 浅島 弘充; 仲地 真一郎; 萩原 清文; 小林 祥子, アレルギー, 61(3):540 - 540, 2012
• Lung disease due to disease-modifying anti-rheumatic drugs, 若林　邦伸;猪熊　茂子, 呼吸器内科, 20(2):118 - 123, Aug. 2011
• 関節リウマチ患者における生物学的製剤無効例に対するタクロリムス併用療法と抑うつ状態, 三輪　裕介;穂坂　路男;松島　大輔;大塚　久美子;佐藤　理仁;髙橋　良;若林　邦伸;小田井　剛;矢嶋　宣幸;笠間　毅, 心身医学, 51(3):254 - 259, Mar. 2011, Peer-reviewed
• Synergistic induction of CX3CL1 by interleukin-1 beta and interferon-gamma in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways, Takeo Isozaki; Kumiko Otsuka; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama, TRANSLATIONAL RESEARCH, 157(2):64 - 70, Feb. 2011
• Synergistic induction of CX3CL1 by interleukin-1 beta and interferon-gamma in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways, Takeo Isozaki; Kumiko Otsuka; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama, TRANSLATIONAL RESEARCH, 157(2):64 - 70, Feb. 2011
• Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis, Michihito Sato; Kumiko Ohtsuka; Ryo Takahashi; Kuninobu Wakabayashi; Tsuyoshi Odai; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama, Open Access Rheumatology: Research and Reviews, 3:1 - 7, 2011
• O42-6 膠原病に関連したマクロファージ活性化症候群(MAS)における血清β2-microglobulin(β2-MG)値(O42 検査,口演,第61回日本アレルギー学会秋季学術大会), 若林 邦伸; 猪熊 茂子; 松原 絵里佳; 大西 香絵; 浅島 弘充; 仲地 真一郎; 萩原 清文; 小林 祥子, アレルギー, 60(9):1426 - 1426, 2011
• O42-6 膠原病に関連したマクロファージ活性化症候群(MAS)における血清β2-microglobulin(β2-MG)値(O42 検査,口演,第61回日本アレルギー学会秋季学術大会), 若林 邦伸; 猪熊 茂子; 松原 絵里佳; 大西 香絵; 浅島 弘充; 仲地 真一郎; 萩原 清文; 小林 祥子, アレルギー, 60(9):1426 - 1426, 2011
• Dermatomyositis complicated with hemorrhagic shock of the iliopsoas muscle on both sides and the thigh muscle, Yusuke Miwa; Mizuho Muramatsu; Ryo Takahashi; Kuninobu Wakabayashi; Tsuyoshi Odai; Takeo Isozaki; Nobuyuki Yajima; Tsuyoshi Kasama, MODERN RHEUMATOLOGY, 20(4):420 - 422, Aug. 2010, Peer-reviewed
• エタネルセプト治療による関節リウマチ患者の抑うつ状態改善の機序, 三輪　裕介;佐藤　理仁;高橋　良;若林　邦伸;小田井　剛;磯崎　健男;矢嶋　宣幸;笠間　毅;穂坂　路男, 臨床リウマチ, 22(1):91 - 98, Apr. 2010, Peer-reviewed
• Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy, Tsuyoshi Kasama; Kuninobu Wakabayashi; Michihito Sato; Ryo Takahashi; Takeo Isozaki, TRANSLATIONAL RESEARCH, 155(1):20 - 26, Jan. 2010
• Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy, Tsuyoshi Kasama; Kuninobu Wakabayashi; Michihito Sato; Ryo Takahashi; Takeo Isozaki, TRANSLATIONAL RESEARCH, 155(1):20 - 26, Jan. 2010
• A case of rheumatoid arthritis with bucillamine-induced yellow nail syndrome initially manifesting as pulmonary disease, Takeo Isozaki; Nobuyuki Yajima; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Yusuke Miwa; Masao Negishi; Hirotsugu Ide; Tsuyoshi Kasama, Clinical Medicine Insights: Case Reports, 3:63 - 68, 2010
• Cytokine-mediated regulation of CX3CL1 in osteoblasts from patients with rheumatoid arthritis, Takeo Isozaki; Michihito Sato; Ryo Takahashi; Kuninobu Wakabayashi; Tsuyoshi Odai; Nobuyuki Yajima; Yusuke Miwa; Masakazu Tezuka; Tsuyoshi Kasama, Immunology and Immunogenetics Insights, 2(1):23 - 29, 2010
• Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis., Isozaki T; Sato M; Takahashi R; Wakabayashi K; Yajima N; Miwa Y; Negishi M; Ide H; Kasama T, Open access rheumatology : research and reviews, 2:29 - 34, 2010
• Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis., Isozaki T; Sato M; Takahashi R; Wakabayashi K; Yajima N; Miwa Y; Negishi M; Ide H; Kasama T, Open access rheumatology : research and reviews, 2:29 - 34, 2010
• Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases., Kasama T; Ohtsuka K; Sato M; Takahashi R; Wakabayashi K; Kobayashi K, Arthritis, 2010:106202, 2010
• Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases., Kasama T; Ohtsuka K; Sato M; Takahashi R; Wakabayashi K; Kobayashi K, Arthritis, 2010:106202, 2010
• Effects of low-dose mizoribine pulse therapy in combination with methotrexate in rheumatoid arthritis patients with an insufficient response to methotrexate, Tsuyoshi Kasama; Kuninobu Wakabayashi; Tsuyoshi Odai; Takeo Isozaki; Mizuho Matsunawa; Nobuyuki Yajima; Yusuke Miwa; Masao Negishi; Hirotsugu Ide, MODERN RHEUMATOLOGY, 19(4):395 - 400, Aug. 2009
• Effects of low-dose mizoribine pulse therapy in combination with methotrexate in rheumatoid arthritis patients with an insufficient response to methotrexate, Tsuyoshi Kasama; Kuninobu Wakabayashi; Tsuyoshi Odai; Takeo Isozaki; Mizuho Matsunawa; Nobuyuki Yajima; Yusuke Miwa; Masao Negishi; Hirotsugu Ide, MODERN RHEUMATOLOGY, 19(4):395 - 400, Aug. 2009
• Correlation of CX3CL1 and CX3CR1 Levels with Response to Infliximab Therapy in Patients with Rheumatoid Arthritis, Tsuyoshi Odai; Mizuho Matsunawa; Ryo Takahashi; Kuninobu Wakabayashi; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama, JOURNAL OF RHEUMATOLOGY, 36(6):1158 - 1165, Jun. 2009
• Correlation of CX3CL1 and CX3CR1 Levels with Response to Infliximab Therapy in Patients with Rheumatoid Arthritis, Tsuyoshi Odai; Mizuho Matsunawa; Ryo Takahashi; Kuninobu Wakabayashi; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Tsuyoshi Kasama, JOURNAL OF RHEUMATOLOGY, 36(6):1158 - 1165, Jun. 2009
• Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis, Mizuho Matsunawa; Tsuyoshi Odai; Kuninobu Wakabayashi; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Kyoko Nohtomi; Hiroko Takeuchi; Tsuyoshi Kasama, Clinical and Experimental Rheumatology, 27(1):72 - 78, Jan. 2009
• Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis, Mizuho Matsunawa; Tsuyoshi Odai; Kuninobu Wakabayashi; Takeo Isozaki; Nobuyuki Yajima; Yusuke Miwa; Kyoko Nohtomi; Hiroko Takeuchi; Tsuyoshi Kasama, Clinical and Experimental Rheumatology, 27(1):72 - 78, Jan. 2009
• Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis., Kanemitsu H; Matsunawa M; Wakabayashi K; Sato M; Takahashi R; Odai T; Isozaki T; Yajima N; Miwa Y; Kasama T, Open access rheumatology : research and reviews, 1:1 - 8, 2009
• Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis., Kanemitsu H; Matsunawa M; Wakabayashi K; Sato M; Takahashi R; Odai T; Isozaki T; Yajima N; Miwa Y; Kasama T, Open access rheumatology : research and reviews, 1:1 - 8, 2009
• Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjogren's syndrome, Tsuyoshi Kasama; Fumitaka Shiozawa; Takeo Isozaki; Mizuho Matsunawa; Kuninobu Wakabayashi; Tsuyoshi Odai; Nobuyuki Yajima; Yusuke Miwa; Masao Negishi; Hirotsugu Ide, MODERN RHEUMATOLOGY, 18(5):455 - 459, Oct. 2008
• Effect of the H2 receptor antagonist nizatidine on xerostomia in patients with primary Sjogren's syndrome, Tsuyoshi Kasama; Fumitaka Shiozawa; Takeo Isozaki; Mizuho Matsunawa; Kuninobu Wakabayashi; Tsuyoshi Odai; Nobuyuki Yajima; Yusuke Miwa; Masao Negishi; Hirotsugu Ide, MODERN RHEUMATOLOGY, 18(5):455 - 459, Oct. 2008
• Clinical features of hemophagocytic syndrome in patients with dermatomyositis, Nobuyuki Yajima; Kuninobu Wakabayashi; Tsuyoshi Odai; Takeo Isozaki; Mizuho Matsunawa; Yusuke Miwa; Masao Negishi; Hirotsugu Ide; Tsuyoshi Kasama, JOURNAL OF RHEUMATOLOGY, 35(9):1838 - 1841, Sep. 2008
• Clinical features of hemophagocytic syndrome in patients with dermatomyositis, Nobuyuki Yajima; Kuninobu Wakabayashi; Tsuyoshi Odai; Takeo Isozaki; Mizuho Matsunawa; Yusuke Miwa; Masao Negishi; Hirotsugu Ide; Tsuyoshi Kasama, JOURNAL OF RHEUMATOLOGY, 35(9):1838 - 1841, Sep. 2008
• Elevated levels of serum macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis, Matsunawa Mizuho; Kanemitsu Hirohito; Wakabayashi Kuninobu; Odai Tsuyoshi; Isozaki Takeo; Yajima Nobuyuki; Miwa Yusuke; Kasama Tsuyoshi, ARTHRITIS AND RHEUMATISM, 58(9):S851, Sep. 2008
• Elevated levels of serum macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis, Matsunawa Mizuho; Kanemitsu Hirohito; Wakabayashi Kuninobu; Odai Tsuyoshi; Isozaki Takeo; Yajima Nobuyuki; Miwa Yusuke; Kasama Tsuyoshi, ARTHRITIS AND RHEUMATISM, 58(9):S851, Sep. 2008
• Effects of low-dose mizoribine pulse therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis, Kasama Tsuyoshi; Wakabayashi Kuninobu; Odai Tsuyoshi; Isozaki Takeo; Matsunawa Mizuho; Yajima Nobuyuki; Miwa Yusuke, ARTHRITIS AND RHEUMATISM, 58(9):S550 - S551, Sep. 2008
• Effects of low-dose mizoribine pulse therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis, Kasama Tsuyoshi; Wakabayashi Kuninobu; Odai Tsuyoshi; Isozaki Takeo; Matsunawa Mizuho; Yajima Nobuyuki; Miwa Yusuke, ARTHRITIS AND RHEUMATISM, 58(9):S550 - S551, Sep. 2008
• Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis, Yusuke Miwa; Takeo Isozaki; Kuninobu Wakabayashi; Tsuyoshi Odai; Mizuho Matsunawa; Nobuyuki Yajima; Masao Negishi; Hirotsugu Ide; Tsuyoshi Kasama; Mitsuru Adachi; Tomoyuki Hisayuki; Tamiko Takemura, MODERN RHEUMATOLOGY, 18(2):208 - 211, Apr. 2008
• Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis, Yusuke Miwa; Takeo Isozaki; Kuninobu Wakabayashi; Tsuyoshi Odai; Mizuho Matsunawa; Nobuyuki Yajima; Masao Negishi; Hirotsugu Ide; Tsuyoshi Kasama; Mitsuru Adachi; Tomoyuki Hisayuki; Tamiko Takemura, MODERN RHEUMATOLOGY, 18(2):208 - 211, Apr. 2008
• Chemokines in systemic lupus erythematosus involving the central nervous system, Tsuyoshi Kasama; Tsuyoshi Odai; Kuninobu Wakabayashi; Nobuyuki Yajima; Yusuke Miwa, FRONTIERS IN BIOSCIENCE-LANDMARK, 13:2527 - 2536, Jan. 2008
• Chemokines in systemic lupus erythematosus involving the central nervous system, Tsuyoshi Kasama; Tsuyoshi Odai; Kuninobu Wakabayashi; Nobuyuki Yajima; Yusuke Miwa, FRONTIERS IN BIOSCIENCE-LANDMARK, 13:2527 - 2536, Jan. 2008
• Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways., Isozaki T; Kasama T; Takahashi R; Odai T; Wakabayashi K; Kanemitsu H; Nohtomi K; Takeuchi HT; Matsukura S; Tezuka M, Journal of inflammation research, 1:19 - 28, 2008
• Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways., Isozaki T; Kasama T; Takahashi R; Odai T; Wakabayashi K; Kanemitsu H; Nohtomi K; Takeuchi HT; Matsukura S; Tezuka M, Journal of inflammation research, 1:19 - 28, 2008
• Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma, Tsuyoshi Kasama; Takeo Isozaki; Tsuyoshi Odai; Mizuho Matsunawa; Kuninobij Wakabayashi; Hiroko T. Takeuchi; Satoshi Matsukura; Mitsuru Adachi; Masakazu Tezuka; Kazuo Kobayashi, TRANSLATIONAL RESEARCH, 149(5):265 - 273, May 2007
• Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma, Tsuyoshi Kasama; Takeo Isozaki; Tsuyoshi Odai; Mizuho Matsunawa; Kuninobij Wakabayashi; Hiroko T. Takeuchi; Satoshi Matsukura; Mitsuru Adachi; Masakazu Tezuka; Kazuo Kobayashi, TRANSLATIONAL RESEARCH, 149(5):265 - 273, May 2007

Presentations

• PeficitinibとFilgotinibは関節リウマチ滑膜線維芽細胞からのVEGFの産生を抑制する, 猪狩　雄蔵;郡司　竜太郎;西見　愛里;西見　慎一郎;石井　翔;徳永　剛広;古屋　秀和;若林　邦伸;磯﨑　健男;笠間　毅, 第65回日本リウマチ学会総会・学術集会, 26 Apr. 2021, Web開催
• Peficitinib inhibits angiogenesis via suppression of VEGF production in rheumatoid arthritis fibroblast-like synoviocytes, IKARI Yuzo;ISOZAKI Takeo;WAKABAYASHI Kuninobu;KASAMA Tsuyoshi, ACR Convergence 2020, 07 Nov. 2020, VIRTUAL
• Cellular analyses in RA HGF/c-MET signaling inhibition abrogates joint destruction by suppressing migration of monocyte to the synovium in rheumatoid arthritis, HOSONUMA Masahiro;FURUYA Hidekazu;NISHIMI Shinichiro;IKARI Yuzo;ISHII Sho;NISHIMI Airi;TOKUNAGA Takahiro;WAKABAYASHI Kuninobu;KASAMA Tsuyoshi;ISOZAKI Takeo, 第64回日本リウマチ学会総会・学術集会, 17 Aug. 2020, Web開催
• 関節リウマチにおけるIL-29の役割の検討, 徳永　剛広;笠間　毅;磯﨑　健男;若林　邦伸;古屋　秀和;石井　翔;猪狩　雄蔵;西見　慎一郎;西見　愛里;細沼　雅弘, 第64回日本リウマチ学会総会・学術集会, 17 Aug. 2020, Web開催
• 全身性強皮症におけるADAM17とBMPR2とのクロストーク, 若林　邦伸;磯﨑　健男;細沼　雅弘;西見　愛里;西見　慎一郎;猪狩　雄蔵;石井　翔;徳永　剛広;古屋　秀和;笠間　毅, 第64回日本リウマチ学会総会・学術集会, 17 Aug. 2020, Web開催
• Filgotinibはヒト骨芽細胞からの炎症性サイトカインの産生を抑制する, 磯﨑　健男;細沼　雅弘;西見　慎一郎;西見　愛里;猪狩　雄蔵;石井　翔;徳永　剛広;古屋　秀和;若林　邦伸;笠間　毅, 第64回日本リウマチ学会総会・学術集会, 17 Aug. 2020, Web開催
• Peficitinibは関節リウマチ滑膜線維芽細胞からのVEGFの産生を抑制する, 猪狩　雄蔵;磯﨑　健男;若林　邦伸;古屋　秀和;徳永　剛広;石井　翔;西見　慎一郎;西見　愛里;細沼　雅弘;笠間　毅, 第64回日本リウマチ学会総会・学術集会, 17 Aug. 2020, Web開催
• 関節リウマチの病因・病態　関節リウマチにおけるvascular endothelial cadherinの発現とA disintegrin and metalloprotease-15との関連の検討, 西見　慎一郎;磯﨑　健男;細沼　雅弘;猪狩　雄蔵;西見　愛里;石井　翔;徳永　剛広;古屋　秀和;若林　邦伸;笠間　毅, 第64回日本リウマチ学会総会・学術集会, 17 Aug. 2020, Web開催
• Inhibitor of DNA binding 1 protein is expressed in rheumatoid arthritis, ISOZAKI Takeo;HOSONUMA Masahiro;NISHIMI Airi;NISHIMI Shinichiro;ISHII Sho;TOKUNAGA Takahiro;IKARI Yuzo;FURUYA Hidekazu;WAKABAYASHI Kuninobu;KASAMA Tsuyoshi, 第63回日本リウマチ学会総会・学術集会, 15 Apr. 2019, 京都
• 関節リウマチ患者における生物学的製剤の使用と血清ADAM-17濃度の検討, 石井　翔;細沼　雅弘;西見　愛里;西見　慎一郎;徳永　剛広;猪狩　雄蔵;古屋　秀和;若林　邦伸;磯﨑　健男;笠間　毅, 第63回日本リウマチ学会総会・学術集会, 15 Apr. 2019, 京都
• Peficitinibの関節リウマチ滑膜線維芽細胞に対する影響の検討, 猪狩　雄蔵;細沼　雅弘;西見　愛里;西見　慎一郎;石井　翔;徳永　剛広;古屋　秀和;若林　邦伸;磯﨑　健男;笠間　毅, 第63回日本リウマチ学会総会・学術集会, 15 Apr. 2019, 京都
• CCL11は関節リウマチの滑膜線維芽細胞の遊走能を増強する, 若林　邦伸;磯﨑　健男;細沼　雅弘;西見　愛里;西見　慎一郎;石井　翔;猪狩　雄蔵;徳永　剛広;古屋　秀和;稲垣　克記;笠間　毅, 第63回日本リウマチ学会総会・学術集会, 15 Apr. 2019, 京都
• リウマチ性疾患の基礎研究-1　IL-17は滑膜線維芽細胞からのVEGF、MCP-1/CCL2、ENA-78/CXCL5の産生を亢進させる, 西見　慎一郎;磯﨑　健男;細沼　雅弘;西見　愛里;石井　翔;徳永　剛広;猪狩　雄蔵;古屋　秀和;若林　邦伸;笠間　毅, 第63回日本リウマチ学会総会・学術集会, 15 Apr. 2019, 京都
• 関節リウマチ滑膜組織におけるフコシル化サイトカインの発現の検討, 磯﨑　健男;西見　慎一郎;西見　愛里;石井　翔;徳永　剛広;猪狩　雄蔵;古屋　秀和;髙橋　良;若林　邦伸;稲垣　克記;笠間　毅, 第62回日本リウマチ学会総会・学術集会, 26 Apr. 2018, 東京
• ADAM-10 as a tocilizumab treatment predictive factor in rheumatoid arthritis., ISOZAKI Takeo;NISHIMI Shinichiro;NISHIMI Airi;ISHII Sho;TOKUNAGA Takahiro;FURUYA Hidekazu;WAKABAYASHI Kuninobu;KASAMA Tsuyoshi, EULAR 2017, 15 Jun. 2017, Madrid
• 関節リウマチ患者におけるADAM-17の発現と滑膜線維芽細胞・単球系細胞におけるその役割, 石井　翔;磯﨑　健男;若林　邦伸;三輪　裕介;笠間　毅;稲垣　克記;中村　正則;豊島　洋一;王　興栄, 第61回日本リウマチ学会総会・学術集会, 20 Apr. 2017, 福岡
• A STUDY ON CHARACTERISTICS OF RHEUMATOID ARTHRITIS PATIENTS ACHIEVING HAQ REMISSION WITH 6 MONTHS OF BIOLOGIC TREATMENT, MIWA Yusuke;TAKAHASHI Ryo;YAJIMA Nobuyuki;WAKABAYASHI Kuninobu;TOKUNAGA Takahiro;ISHII Sho;NISHIMI Airi;KASAMA Tsuyoshi;OH Koei;TOYOSHIMA Yoichi;INAGAKI Katsunori, EULAR 2015, 10 Jun. 2015, Rome
• 関節リウマチ患者におけるinfliximab治療はmethotrexate単独治療よりも抑うつ状態の改善に優位性が認められるか, 三輪　裕介;齋藤　麻由;磯島　咲子;梅村　方裕;柳井　亮;古屋　秀和;若林　邦伸;磯﨑　健男;矢嶋　宣幸;笠間　毅, 第112回日本内科学会総会・講演会, 12 Apr. 2015, 京都
• ADAM-10 as a tocilizumab treatment predictive factor in rheumatoid arthritis, ISOZAKI Takeo;ISOJIMA Sakiko;TOKUNAGA Takahiro;UMEMURA Masayu;古屋　秀和;YANAI Ryo;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;MIWA Yusuke;KASAMA Tsuyoshi, 2014 ACR/ARHP Annual Meeting, 18 Nov. 2014, Boston
• TACROLIMUS THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS WITH OR WITHOUT RENAL INVOLVEMENT DURING THE MAINTENANCE PHASE, OHTSUKA Kumiko;MIWA Yusuke;OGURO Nao;MIURA Yoko;ISHII Sho;SEKI Shinya;FURUYA Hidekazu;YANAI Ryo;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;ISOZAKI Takeo;YAJIMA Nobuyuki;KASAMA Tsuyoshi, EULAR 2014, 14 Jun. 2014, Paris
• Assessment of the treatment of glucocorticoid induced osteoporosis in antineutrophil cytoplasmic antibody-associated vasculitis, 若林　邦伸;小黒　奈緒;三浦　瑶子;石井　翔;関　慎也;梅村　方裕;徳永　剛広;塚本　裕之;磯島　咲子;柳井　亮;古屋　秀和;大塚　久美子;髙橋　良;磯崎　健男;矢嶋　宣幸;三輪　裕介;笠間　毅, 第58回日本リウマチ学会総会・学術集会, 25 Apr. 2014, 東京
• The risk factors of aseptic necrosis of the femoral head (ANF) in Systemic Lupus Erythematosus : Case Control Study, 矢嶋　宣幸;石井　翔;関　慎也;小黒　奈緒;三浦　瑶子;徳永　剛広;塚本　裕之;梅村　方裕;柳井　亮;古屋　秀和;大塚　久美子;髙橋　良;磯島　咲子;若林　邦伸;小田井　剛;磯﨑　健男;三輪　裕介;根岸　雅夫;井出　宏嗣;笠間　毅, 第58回日本リウマチ学会総会・学術集会, 25 Apr. 2014, 東京
• 心筋障害を合併した好酸球性多発血管炎性肉芽腫症(EGPA)の一例, 三浦　瑶子;石井　翔;小黒　奈緒;関　慎也;徳永　剛広;塚本　裕之;梅村　方裕;柳井　亮;古屋　秀和;大塚　久美子;髙橋　良;磯島　咲子;若林　邦伸;磯﨑　健男;矢嶋　宣幸;三輪　裕介;根岸　雅夫;井出　宏嗣;笠間　毅, 第58回日本リウマチ学会総会・学術集会, 24 Apr. 2014, 東京
• 関節リウマチ患者に生物学的製剤を使用することによる薬剤の有効性、ADL、QOL、抑うつ状態の改善には男女差があるか, 三輪　裕介;三浦　瑶子;小黒　奈緒;関　慎也;石井　翔;梅村　方裕;塚本　裕之;徳永　剛広;磯島　咲子;柳井　亮;古屋　秀和;大塚　久美子;若林　邦伸;磯﨑　健男;矢嶋　宣幸;笠間　毅;穂坂　路男, 第58回日本リウマチ学会総会・学術集会, 24 Apr. 2014, 東京
• EFFICACY OF TACROLIMUS COMBINATION THERAPY DURING THE MAINTENANCE PHASE OF SYSTEMIC LUPUS ERYTHEMATOSUS, OHTSUKA Kumiko;MIWA Yusuke;OGURO Nao;MIURA Yoko;ISHII Sho;SEKI Shinya;FURUYA Hidekazu;YANAI Ryo;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;KASAMA Tsuyoshi, 2013 ACR/ARHP Annual Meeting, 28 Oct. 2013, San Diego
• Plasma levels of fibrin/fibrinogen degradation products might be a useful indicator of disease activity, classification and nephritis complications in antineutrophil cytoplasmic antibody-associated vasculitis, WAKABAYASHI Kuninobu;OGURO Nao;MIURA Yoko;ISHII Sho;SEKI Shinya;UMEMURA Masayu;TOKUNAGA Takahiro;TSUKAMOTO Hiroyuki;ISOJIMA Sakiko;FURUYA Hidekazu;YANAI Ryo;OTSUKA Kumiko;TAKAHASHI Ryo;ISOZAKI Takeo;YAJIMA Nobuyuki;MIWA Yusuke;KASAMA Tsuyoshi, 2013 ACR/ARHP Annual Meeting, 27 Oct. 2013, San Diego
• Plasma levels of fibrin/fibrinogen degradation products are a useful indicator of disease activity and nephritis complications in antineutrophil cytoplasmic antibody-associated vasculitis, WAKABAYASHI Kuninobu;UMEMURA Masayu;TOKUNAGA Takahiro;TSUKAMOTO Hiroyuki;ISOJIMA Sakiko;FURUYA Hidekazu;YANAI Ryo;OTSUKA Kumiko;TAKAHASHI Ryo;YAJIMA Nobuyuki;MIWA Yusuke;KASAMA Tsuyoshi, EULAR 2013, 15 Jun. 2013, Madrid
• SWITCHING BIOLOGIC AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN OBSERVATIONAL STUDY OF 159 PATIENTS EVALUATING EFFICACY, ADL, QOL, AND DEPRESSION, MIWA Yusuke;ISOJIMA Sakiko;UMEMURA Masayu;TOKUNAGA Takahiro;FURUYA Hidekazu;YANAI Ryo;OHTSUKA Kumiko;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;KASAMA Tsuyoshi;HOSAKA Michio, EULAR 2013, 12 Jun. 2013, Madrid
• CORRELATION OF CX3CL1 LEVELS WITH ADL, HRQOL AND DEPRESSION TO BIOLOGIC AGENT THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS, MIWA Yusuke;ISOJIMA Sakiko;UMEMURA Masayu;TSUKAMOTO Hiroyuki;TOKUNAGA Takahiro;FURUYA Hidekazu;YANAI Ryo;OHTSUKA Kumiko;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;KASAMA Tsuyoshi;HOSAKA Michio, EULAR 2013, 12 Jun. 2013, Madrid
• EFFICACY OF TACROLIMUS COMBINATION THERAPY DURING THE MAINTENANCE PHASE OF SYSTEMIC LUPUS ERYTHEMATOSUS, OHTSUKA Kumiko;MIWA Yusuke;UMEMURA Masayu;TOKUNAGA Takahiro;TSUKAMOTO Hiroyuki;FURUYA Hidekazu;YANAI Ryo;ISOJIMA Sakiko;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;KASAMA Tsuyoshi, EULAR 2013, 12 Jun. 2013, Madrid
• Plasma levels of fibrin/fibrinogen degradation products are a useful indicator of disease activity and nephritis complications in antineutrophil cytoplasmic antibody-associated vasculitis, 若林　邦伸;梅村　方裕;徳永　剛広;塚本　裕之;磯島　咲子;古屋　秀和;柳井　亮;大塚　久美子;髙橋　良;矢嶋　宣幸;三輪　裕介;笠間　毅, 第57回日本リウマチ学会総会・学術集会・第22回国際リウマチシンポジウム, 20 Apr. 2013, 京都
• 関節リウマチの治療　生物学的製剤(TNF阻害薬) 関節リウマチ治療における生物学的製剤は1剤目、2剤目、3剤目で有効性、ADL、QOL、抑うつ状態に差があるか, 三輪　裕介;磯島　咲子;梅村　方裕;塚本　裕之;徳永　剛広;古屋　秀和;柳井　亮;大塚　久美子;TAKAHASHI Ryo;若林　邦伸;矢嶋　宣幸;笠間　毅;穂坂　路男, 第57回日本リウマチ学会総会・学術集会・第22回国際リウマチシンポジウム, 18 Apr. 2013, 京都
• COMPARISON OF EFFICACY OF FOUR BIOLOGICAL AGENTS FOR RHEUMATOID ARTHRITIS PATIENTS USING THE HRQOL QUESTIONNAIRE AND DEPRESSION SCALE, MIWA Yusuke;FURUYA Hidekazu;YANAI Ryo;OHTSUKA Kumiko;SATO Michihito;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;KASAMA Tsuyoshi;HOSAKA Michio, EULAR 2012, 06 Jun. 2012, Berlin
• FACTORS LEADING TO HAQ REMISSION AFTER BEGINNING BIOLOGICS TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS, MIWA Yusuke;FURUYA Hidekazu;YANAI Ryo;OHTSUKA Kumiko;SATO Michihito;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;YAJIMA Nobuyuki;KASAMA Tsuyoshi;HOSAKA Michio, EULAR 2012, 06 Jun. 2012, Berlin
• EFFICACY OF TACROLIMUS COMBINATION THERAPY DURING THE MAINTENANCE PHASE OF SYSTEMIC LUPUS ERYTHEMATOSUS, OHTSUKA Kumiko;MIWA Yusuke;FURUYA Hidekazu;YANAI Ryo;SATO Michihito;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;ODAI Tsuyoshi;YAJIMA Nobuyuki;KASAMA Tsuyoshi, EULAR 2012, 06 Jun. 2012, Berlin
• Clinically amyopathic dermatomyositis (CADM)の活動性の評価に血清β2-microglobulin値が有用であった1例, 若林　邦伸;猪熊　茂子;松原　絵里佳;大西　香絵;浅島　弘充;仲地　真一郎;萩原　清文;小林　祥子, 第24回日本アレルギー学会春季臨床大会, 12 May 2012, 大阪
• 生物学的製剤(TNF阻害薬)　HAQ・患者評価 関節リウマチ患者に対する生物学的製剤4剤の有効性、QOL、抑うつ状態との比較検討, 三輪　裕介;古屋　秀和;柳井　亮;大塚　久美子;佐藤　理仁;髙橋　良;若林　邦伸;小田井　剛;磯﨑　健男;矢嶋　宣幸;笠間　毅;穂坂　路男, 第56回日本リウマチ学会総会・学術集会・第21回国際リウマチシンポジウム, 26 Apr. 2012, 東京
• Serum levels of beta 2-microglobulin in systemic lupus erythmatosus patients, 若林　邦伸;猪熊　茂子;松原　絵里佳;大西　香絵;浅島　弘充;仲地　真一郎;萩原　清文;小林　祥子, 第56回日本リウマチ学会総会・学術集会, 26 Apr. 2012, 東京
• 膠原病に関連したマクロファージ活性化症候群（MAS）における血清β2-microglobulin（β2-MG）値, 若林　邦伸;猪熊　茂子;松原　絵里佳;大西　香絵;浅島　弘充;仲地　真一郎;萩原　清文;小林　祥子, 第61回日本アレルギー学会秋季学術大会, 11 Nov. 2011, 東京
• ANCA関連血管炎におけるFDP値の検討, 若林　邦伸;大塚　久美子;佐藤　理仁;高橋　良;小田井　剛;磯崎　健男;矢嶋　宣幸;三輪　裕介;根岸　雅夫;井出　宏嗣;笠間　毅, 第55回日本リウマチ学会総会・学術集会・第20回国際リウマチシンポジウム, 20 Jul. 2011, 神戸
• 生物学的製剤にてHAQ寛解に至る関節リウマチ患者の背景についての検討, 三輪　裕介;大塚　久美子;佐藤　理仁;髙橋　良;若林　邦伸;小田井　剛;磯﨑　健男;矢嶋　宣幸;古屋　秀和;笠間　毅;穂坂　路男, 第55回日本リウマチ学会総会・学術集会・第20回国際リウマチシンポジウム, 17 Jul. 2011, 神戸
• POSITIVE BIOLOGICS AGENT TREATMENT RESPONSE IMPROVES THE HEALTH-RELATED QUALITY OF LIFE AND DEPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS, MIWA Yusuke;OHTSUKA Kumiko;SATO Michihito;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;ISOZAKI Takeo;YAJIMA Nobuyuki;KASAMA Tsuyoshi;HOSAKA Michio, EULAR 2011, 25 May 2011, London
• BACKGROUND FEATURE OF THE REACHING HAQ REMISSION BY BIOLOGICS AGENT TREATMENT FOR RA, MIWA Yusuke;OHTSUKA Kumiko;SATO Michihito;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;ODAI Tsuyoshi;ISOZAKI Takeo;YAJIMA Nobuyuki;KASAMA Tsuyoshi;HOSAKA Michio, EULAR 2011, 25 May 2011, London
• Effects of the health-related QOL and depression by low-dose tacrolimus combination therapy with biologics agent in patients with biologics agent-refractory rheumatoid arthritis, SATO Michihito;TAKAHASHI Ryo;WAKABAYASHI Kuninobu;ODAI Tsuyoshi;ISOZAKI Takeo;YAJIMA Nobuyuki;HOSAKA Michio;MIWA Yusuke, EULAR 2010, 01 Jun. 2010, Rome
• 関節リウマチ患者に対する生物学的製剤の有効性とQOL、抑うつ状態の関係, 三輪　裕介;佐藤　理仁;髙橋　良;若林　邦伸;小田井　剛;磯﨑　健男;矢嶋　宣幸;根岸　雅夫;井出　宏嗣;笠間　毅;穂坂　路男, 第54回日本リウマチ学会総会・学術集会, 01 Apr. 2010, 神戸